Metagenomi, Inc. (MGX) Stock Statistics & Valuation Metrics

Metagenomi, Inc. has a market cap or net worth of $66.21M. The enterprise value is $60.51M.

Metagenomi, Inc. has 37,620,530 shares outstanding. The number of shares has decreased by -2.65% in one year.

Metagenomi, Inc.’s return on equity (ROE) is -0.55 and return on invested capital (ROIC) is -46.99%.

The current PE Ratio of Metagenomi, Inc. is ―. Metagenomi, Inc.’s PEG ratio is -0.05.

In the last 12 months, Metagenomi, Inc. had revenue of 25.21M and earned -87.87M in profits. Earnings per share was -2.36.

In the last 12 months, operating cash flow was -88.89M and capital expenditures -574.00K, giving a free cash flow of -89.47M billion.

Metagenomi, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Metagenomi, Inc. upcoming earnings date is May 19, 2026, Before Open (Confirmed).

Metagenomi, Inc. as a current ratio of 7.22, with Debt / Equity ratio of 25.64%

In the past 12 months, Metagenomi, Inc. has paid -58.00K in taxes.

Metagenomi, Inc. EV to EBITDA ratio is -0.65, with an EV/FCF ratio of -0.66.

Metagenomi, Inc. has $160.80M in cash and marketable securities with $40.66M in debt, giving a net cash position of $120.14M billion.

Gross margin is 0.31%, with operating margin of -380.85%, and net profit margin of -348.54%.

The average price target for Metagenomi, Inc. is $9.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy